{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:52:11Z","timestamp":1793040731152,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004168","name":"Universit\u00e4t zu L\u00fcbeck","doi-asserted-by":"publisher","award":["2023-133 18.01.2023\/ IK"],"award-info":[{"award-number":["2023-133 18.01.2023\/ IK"]}],"id":[{"id":"10.13039\/501100004168","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.clinthera.2024.12.004","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T20:47:42Z","timestamp":1735332462000},"page":"e13-e21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Polyneuropathy in Parkinson's Disease is Highly Prevalent and Not Related to Treatment"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8054-4313","authenticated-orcid":false,"given":"Valeria","family":"Sajin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Jahnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uazman","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Macerollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2024.12.004_bib0001","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mdc3.12688","article-title":"Levodopa-induced neuropathy: a systematic review","volume":"6","author":"Romagnolo","year":"2018","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0002","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1212\/WNL.0b013e31823a0ee4","article-title":"Neuropathy in Parkinson disease: prevalence and determinants","volume":"77","author":"Rajabally","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0003","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jns.2017.05.023","article-title":"Peripheral neuropathy in idiopathic Parkinson's disease: a systematic review","volume":"378","author":"Zis","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0004","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/brain\/awac026","article-title":"Peripheral neuropathy in Parkinson's disease: prevalence and functional impact on gait and balance","volume":"146","author":"Corr\u00e0","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.parkreldis.2018.04.006","article-title":"Peripheral neuropathy is associated with more frequent falls in Parkinson's disease","volume":"54","author":"Beaulieu","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0006","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/acn3.51182","article-title":"Correlates of polyneuropathy in Parkinson's disease","volume":"7","author":"K\u00fchn","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0007","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.25585","article-title":"Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study","volume":"28","author":"Ceravolo","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0008","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/mds.27025","article-title":"Peripheral neuropathy as marker of severe Parkinson's disease phenotype","volume":"32","author":"Merola","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0009","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3390\/jcm8101533","article-title":"Large-Fiber Neuropathy in Parkinson's disease: clinical, biological, and electroneurographic assessment of a Romanian cohort","volume":"8","author":"Vanta","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0010","doi-asserted-by":"crossref","first-page":"e2675","DOI":"10.6061\/clinics\/2021\/e2675","article-title":"Parkinson-related neuropathy","volume":"76","author":"Finsterer","year":"2021","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0011","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0012","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/mds.27362","article-title":"Validation of the MDS clinical diagnostic criteria for Parkinson's disease","volume":"33","author":"Postuma","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0013","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0014","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0015","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0016","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s42466-020-00064-2","article-title":"Diagnosis of peripheral neuropathy","volume":"2","author":"Lehmann","year":"2020","journal-title":"Neurol Res Pract"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171597","article-title":"The sensitivity and specificity of the neurological examination in polyneuropathy patients with clinical and electrophysiological correlations","volume":"12","author":"Abraham","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0018","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1136\/jnnp.2003.016550","article-title":"Repetitive training of compensatory steps: a therapeutic approach for postural instability in Parkinson's disease","volume":"75","author":"J\u00f6bges","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0019","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1590\/0004-282X20140082","article-title":"Pull test performance and correlation with falls risk in Parkinson's disease","volume":"72","author":"Munhoz","year":"2014","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.gaitpost.2023.05.005","article-title":"Objective quantification of responses to the clinical pull-test in people with Parkinson's disease","volume":"103","author":"Virmani","year":"2023","journal-title":"Gait Posture"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0021","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000149522.32823.EA","article-title":"Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"64","author":"England","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2024.12.004_sbref0022","series-title":"Deutsche Gesellschaft f\u00fcr Neurologie (Hrsg.)","article-title":"Diagnostik bei Polyneuropathien, S1-Leitlinie","author":"Heu\u00df","year":"2019"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0023","series-title":"Electromyography and Neuromuscular Disorders","author":"Preston","year":"2005"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0024","series-title":"EMG NLG","author":"Bischoff","year":"2018"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0025","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.clinph.2005.04.003","article-title":"Pathophysiology inferred from electrodiagnostic nerve tests and classification of polyneuropathies. Suggested guidelines","volume":"116","author":"Tankisi","year":"2005","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinthera.2024.12.004_sbref0026","series-title":"StatPearls","article-title":"Electrodiagnostic evaluation of peripheral neuropathy","author":"Novello","year":"2023"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0027","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/jdi.13188","article-title":"Diabetic polyneuropathy: progress in diagnostic strategy and novel target discovery, but stagnation in drug development","volume":"11","author":"Himeno","year":"2020","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0028","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/mdc3.12921","article-title":"Levodopa equivalent dose conversion factors: an updated proposal including opicapone and safinamide","volume":"7","author":"Schade","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0029","unstructured":"GraphPad Prism version 9. https:\/\/www.graphpad.com\/features. Accessed August 6, 2024."},{"key":"10.1016\/j.clinthera.2024.12.004_bib0030","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1046\/j.1532-5415.2002.50503.x","article-title":"Factors associated with falls in older patients with diffuse polyneuropathy","volume":"50","author":"Richardson","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0031","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12877-018-0970-5","article-title":"The pace and prognosis of peripheral sensory loss in advanced age: association with gait speed and falls","volume":"18","author":"Lipsitz","year":"2018","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0032","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/1980-5764-dn-2021-0019","article-title":"Falls in Parkinson's disease: the impact of disease progression, treatment, and motor complications","volume":"16","author":"Lima","year":"2022","journal-title":"Dement Neuropsychol"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0033","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.3390\/ijerph16122216","article-title":"Falls in Parkinson's disease subtypes: risk factors, locations and circumstances","volume":"16","author":"Pelicioni","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0034","article-title":"Interventions for preventing falls in Parkinson's disease","volume":"6","author":"Allen","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0035","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s13760-023-02428-2","article-title":"Prognostic factors for falls in Parkinson's disease: a systematic review","volume":"124","author":"Murueta-Goyena","year":"2024","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0036","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1007\/s00415-024-12579-8","article-title":"Longitudinal evaluation of polyneuropathy in Parkinson's disease","volume":"271","author":"Kwon","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0037","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jns.2018.06.012","article-title":"The influence of levodopa, entacapone and homocysteine on prevalence of polyneuropathy in patients with Parkinson's disease","volume":"392","author":"Grofik","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104076","article-title":"Skin alpha-synuclein deposit patterns: a predictor of Parkinson's disease subtypes","volume":"80","author":"Han","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0039","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fneur.2019.00111","article-title":"Increased intraepidermal nerve fiber degeneration and impaired regeneration relate to symptoms and deficits in Parkinson's disease","volume":"10","author":"Jeziorska","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0040","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1007\/s10072-020-04407-4","article-title":"Peripheral neuropathy in Parkinson's disease","volume":"41","author":"Paul","year":"2020","journal-title":"Neurol Sci"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0041","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s10072-017-3056-9","article-title":"Serum methylmalonic acid correlates with neuropathic pain in idiopathic Parkinson's disease","volume":"38","author":"Park","year":"2017","journal-title":"Neurol Sci"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0042","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-014-1284-0","article-title":"Cutaneous neuropathy in Parkinson's disease: a window into brain pathology","volume":"128","author":"Doppler","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0043","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/ene.12912","article-title":"Peripheral neuropathy and levodopa therapy in Parkinson disease: novel insights","volume":"23","author":"Kimber","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0044","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.clinph.2021.11.038","article-title":"HP40: aging: an influencing factor in large fibers neuropathy during idiopathic Parkinson disease","volume":"135","author":"Chakroun","year":"2022","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0045","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.parkreldis.2014.10.010","article-title":"Peripheral nervous system involvement in Parkinson's disease: evidence and controversies","volume":"20","author":"Comi","year":"2014","journal-title":"Parkinsonsim Relat Disord"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0046","doi-asserted-by":"crossref","DOI":"10.1212\/01.WNL.0000158674.91134.6E","article-title":"The effect of entacapone on homocysteine levels in Parkinson disease","volume":"64","author":"Ostrem","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0047","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mds.20261","article-title":"Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients","volume":"20","author":"Lamberti","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinthera.2024.12.004_bib0048","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.parkreldis.2016.04.016","article-title":"Levodopa and neuropathy risk in patients with Parkinson disease: effect of COMT inhibition","volume":"27","author":"Cossu","year":"2016","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824004016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824004016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T21:10:05Z","timestamp":1740345005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291824004016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0149291824004016"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.12.004","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyneuropathy in Parkinson's Disease is Highly Prevalent and Not Related to Treatment","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}